JAG
BSX icon

Journey Advisory Group’s Boston Scientific BSX Stock Holding History

Journey Advisory Group’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.26M Buy
99,696
+93,846
+1,604% +$5.1M 0.33% 86
2026
Q1 		$367K Sell
5,850
-2,200
-27% -$176K 0.03% 202
2025
Q4 		$768K Sell
8,050
-350
-4% -$34.3K 0.06% 168
2025
Q3 		$820K Buy
8,400
+1,000
+14% +$104K 0.06% 163
2025
Q2 		$795K Buy
7,400
+500
+7% +$50.6K 0.06% 175
2025
Q1 		$696K Sell
6,900
-1,950
-22% -$196K 0.06% 175
2024
Q4 		$682K Hold
8,850
– – 0.08% 130
2024
Q3 		$682K Hold
8,850
– – 0.08% 130
2024
Q2 		$682K Sell
8,850
-3,875
-30% -$284K 0.08% 130
2024
Q1 		$872K Hold
12,725
– – 0.11% 122
2023
Q4 		$736K Sell
12,725
-80
-0.6% -$4.27K 0.1% 123
2023
Q3 		$676K Buy
12,805
+3,875
+43% +$203K 0.1% 127
2023
Q2 		$483K Hold
8,930
– – 0.07% 151
2023
Q1 		$447K Buy
8,930
+500
+6% +$23.6K 0.07% 159
2022
Q4 		$390K Sell
8,430
-2,850
-25% -$123K 0.1% 154
2022
Q3 		$437K Sell
11,280
-1,220
-10% -$48.9K 0.11% 151
2022
Q2 		$513K Buy
+12,500
New +$509K 0.12% 147
2022
Q1 		– Sell
-5,000
Closed -$212K – 219
2021
Q4 		$212K Hold
5,000
– – 0.06% 201
2021
Q3 		$217K Sell
5,000
-500
-9% -$22.1K 0.07% 186
2021
Q2 		$235K Hold
5,500
– – 0.07% 188
2021
Q1 		$213K Buy
+5,500
New +$208K 0.07% 186

Other funds holding BSX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Amundi
Amundi Paris, France $413B AUM 44.57% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Vontobel Holding
Vontobel Holding Zurich, Switzerland $31.4B AUM 31.97% 1-Year Est. Return
Swiss National Bank
Swiss National Bank Zurich, Switzerland $191B AUM 45.21% 1-Year Est. Return

Journey Advisory Group's BSX Position: Q2 2026 in Review

Journey Advisory Group increased its Boston Scientific (BSX) stake by 1,604% in Q2 2026, buying an estimated $5.1M and bringing the position to 99,696 shares worth $4.26M. The position accounts for 0.33% of the portfolio, ranked #86.

Journey Advisory Group first reported a position in BSX in Q1 2021 and has held it in 21 quarters since. 932 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

  • Journey Advisory Group held 99,696 shares of Boston Scientific worth $4.26M as of Q2 2026.
  • Journey Advisory Group bought 93,846 Boston Scientific shares in Q2 2026, an estimated $5.1M.
  • Boston Scientific made up 0.33% of Journey Advisory Group's portfolio in Q2 2026, its #86 holding.
  • Journey Advisory Group first reported a position in Boston Scientific in Q1 2021 and has held it in 21 quarters since.
  • 932 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on Journey Advisory Group's 13F filing for Q2 2026, filed 4 Aug 2026.